Nomura Holdings
BPMC

Nomura Holdings’s Blueprint Medicines BPMC Stock Holding History

Nomura Holdings’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-50,000
Closed -$4.74M – 1771
2024
Q1 		$4.74M Buy
+50,000
New +$4.29M 0.01% 651

Other funds holding BPMC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nomura Holdings's BPMC Position: Q3 2024 in Review

Nomura Holdings sold out of Blueprint Medicines (BPMC) in Q3 2024, closing a stake of 2,506 shares — an estimated $270K sold.

Nomura Holdings first reported a position in BPMC in Q2 2019 and held it in 12 quarters. The position peaked at $5.67M in Q4 2022. 319 funds tracked by Wall St. Rank hold BPMC as of Q3 2024.

  • Nomura Holdings reported no remaining Blueprint Medicines position as of Q3 2024 after selling out during the quarter.
  • Nomura Holdings sold 2,506 Blueprint Medicines shares in Q3 2024, an estimated $270K.
  • Nomura Holdings first reported a position in Blueprint Medicines in Q2 2019 and held it in 12 quarters.
  • Nomura Holdings's Blueprint Medicines position peaked at $5.67M in Q4 2022.
  • 319 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2024.

Based on Nomura Holdings's 13F filing for Q3 2024, filed 14 Nov 2024.